0.5 CME Credits. This webinar is a 30-minute overview of psychological and psychodynamic factors that can impact the psychopharmacological treatment of patients.
0.5 CME Credits. This webinar is a comprehensive 30-minute overview of psychodynamic principles, processes, and evolution for mental health professionals.
0.75 CME Credits. This webinar discusses ADHD and its varied presentations, co-occurring issues, and the importance of accurate assessment for effective treatment.
0.25 CME Credits. In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials. First, we dive into the recent charges brought by the US Department of Justice against executives at Done, a California-based telehealth company, for alleged healthcare fraud. Done is accused of prescribing over 40 million Adderall pills to patients without proper evaluation, raising concerns about the balance between increasing mental healthcare access and responsible prescribing practices.
Psilocybin is going mainstream: Trump has signed an executive order opening psychedelics to patients with severe mental illness, and one in eight American adults has already tried it. But as we dig into the research, a more complicated picture emerges, one that separates the profound personal experience from the clinical evidence.
What if the patients we assume are safest from suicide are actually the ones we miss? Today we're talking about suicide risk in autistic youth, why it's higher than many clinicians expect, how distress shows up differently, and what small changes in our assessment process and treatment can make a real difference.
It's 1979, and Johns Hopkins has just shut down the first gender surgery clinic in the US. But investigations into the biological roots of gender identity are about to reopen those doors — and reshape how medicine thinks about sex, gender, and who gets to decide.
In 1966, Johns Hopkins opened the first gender surgery clinic in the US. Thirteen years later, a single study shut it down. We examine what the research said, what it didn't say, and how new standards of care emerged from the ashes.
Five free episodes on the issues that matter most in child and adolescent psychiatry today — from suicide risk in autistic youth to anxiety, sleep, legal systems, and expanding access to care. Hosted by Dr. Joshua Feder and Mara Goverman, LCSW.
For 23 years, Dr. Carlat and his team of clinical experts have developed a mountain of peer-reviewed articles and books covering almost every aspect of psychiatry. Unlike many journals, these resources are straightforward, plain spoken, and actionable for the everyday work clinicians face. This year we took that massive archive and put it to work for you in a brand new interface called AskCarlat AI.
Two malpractice cases — one worth $2 million — are reshaping the standards of gender-affirming care. This episode traces what went wrong, what held up in court, and what every clinician needs to know when referring patients for gender affirming procedures.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
